cyc 202 has been researched along with Nerve Degeneration in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hyun, HW; Kim, JE; Min, SJ | 1 |
| Hernandez, P; Lee, G; Maccioni, RB; Sjoberg, M | 1 |
| Huttunen, HJ; Kysenius, K; Nykänen, NP; Sakha, P; Tammela, P | 1 |
| Bu, B; Chakrabarty, P; Li, J; Vincent, I; Zhang, M | 1 |
| Ackerley, S; Brownlees, J; Kesavapany, S; Lau, KF; Leigh, PN; McLoughlin, DM; Miller, CC; Shaw, CE | 1 |
5 other study(ies) available for cyc 202 and Nerve Degeneration
| Article | Year |
|---|---|
CDK5 inhibitors prevent astroglial apoptosis and reactive astrogliosis by regulating PKA and DRP1 phosphorylations in the rat hippocampus.
Topics: Animals; Apoptosis; Astrocytes; CA1 Region, Hippocampal; Cyclic AMP-Dependent Protein Kinases; Cyclin-Dependent Kinase 5; Dentate Gyrus; Dynamins; Gliosis; Kinetin; Male; Nerve Degeneration; Phosphorylation; Protein Kinase Inhibitors; Purines; Rats; Roscovitine; Status Epilepticus | 2017 |
Tau phosphorylation by cdk5 and Fyn in response to amyloid peptide Abeta (25-35): involvement of lipid rafts.
Topics: Amyloid beta-Peptides; Cell Line; Cyclin-Dependent Kinase 5; Growth Inhibitors; Humans; Membrane Microdomains; Nerve Degeneration; Peptide Fragments; Phosphorylation; Proto-Oncogene Proteins c-fyn; Purines; Roscovitine; tau Proteins | 2009 |
γ-Aminobutyric acid type A (GABAA) receptor activation modulates tau phosphorylation.
Topics: Alzheimer Disease; Animals; Cell Line, Tumor; Cyclin-Dependent Kinase 5; Cytoskeleton; Enzyme Inhibitors; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Marine Toxins; Mice; Naphthoquinones; Nerve Degeneration; Neuroblastoma; NIMA-Interacting Peptidylprolyl Isomerase; Oxazoles; Peptidylprolyl Isomerase; Phosphorylation; Protein Kinase Inhibitors; Protein Phosphatase 2; Purines; Rats; Receptors, GABA-A; Roscovitine; tau Proteins; Tauopathies | 2012 |
Cyclin-dependent kinase inhibitors attenuate protein hyperphosphorylation, cytoskeletal lesion formation, and motor defects in Niemann-Pick Type C mice.
Topics: Animals; Apoptosis; Cyclin-Dependent Kinases; Cytoskeleton; Disease Models, Animal; Enzyme Inhibitors; Female; Humans; Intracellular Signaling Peptides and Proteins; Kinetin; Male; Mice; Mice, Inbred BALB C; Mice, Neurologic Mutants; Motor Activity; Nerve Degeneration; Neurons; Niemann-Pick C1 Protein; Niemann-Pick Diseases; Phosphorylation; Proteins; Purines; Purkinje Cells; Roscovitine; tau Proteins | 2004 |
p35/cdk5 binds and phosphorylates beta-catenin and regulates beta-catenin/presenilin-1 interaction.
Topics: Alzheimer Disease; Animals; beta Catenin; Calpain; Cerebral Cortex; CHO Cells; Cricetinae; Cyclin-Dependent Kinase 5; Cyclin-Dependent Kinases; Cytoskeletal Proteins; Enzyme Inhibitors; Humans; Kidney; Membrane Proteins; Nerve Degeneration; Nerve Tissue Proteins; Phosphorylation; Presenilin-1; Protein Binding; Purines; Rats; Roscovitine; Trans-Activators | 2001 |